The authors first evaluated patients with sarcopenia, osteoporosis, or osteosarcopenia, and found significantly decreased levels of IL-33 in skeletal muscle, bone matrix, proximal bone marrow, and serum of osteosarcopenia patients. The gene discussed is IL33; the disease is osteoporosis.